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i,	the	cumulative	BED	bi	of	all	fractions	is	given	by		() 	= 	 +), + +),.(!/#))1,23 	
where	dit	is	the	dose	delivered	in	fraction	t,	n	is	the	number	of	fractions,	and	(!/#)) 	is	the	!/#-ratio	of	the	structure	that	voxel	i	belongs	to.		
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8
A Patients9
Five patients were selected as to represent a spectrum of tumor geometries, locations and10
sizes. Patient 1 has 4 metastases of varying size located throughout the right lobe of the liver11
and the total GTV volume is 391 cc. Patient 2 has one lesion (201 cc) peripherally located in12
the right lobe; patient 3 has one large and one small metastasis centrally located in the right13
lobe with a total GTV volume of 207 cc; patient 4 has a single lesion in the inferior part of14
the right lobe (228 cc), which abuts the small bowel, the stomach, and chest wall; patient 515
has one very large lesion (647 cc) in the inferior part of the liver.16
B Treatment plan optimization17
In this section we detail the treatment plan optimization methods. Simultaneous optimiza-18
tion for multiple treatment plans for spatiotemporal fractionstion is based on objective and19
constraint functions evaluated for cumulative BED b.20
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B.1 Optimization of reference plan and spatiotemporal plan 121
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bi (mean BED in the liver without GTV, ↵/  = 4) (6)28
29














Dijxtj 8i, t (physical dose in voxel i in fraction t) (9)32
xtj   0 8j, t (non-negative fluence) (10)33
Here, t indexes the fractions that deliver distinct dose distributions, T is the number of dis-34
tinct dose distributions, and nt is the number of times fraction t is delivered. Hence, for the35
reference plan we have T = 1. xtj denotes the fluence of beamlet j in fraction t and dti are36
the physical doses per fraction in voxel i in fraction t. The dose-deposition matrix elements37
Dij denotes the dose contributions of beamlets j to voxel i for unit fluence. G and P denote38
the sets of voxels contained in the GTV and the PTV, respectively; W is the set of voxels in39
the chest wall; L denotes all voxels in the liver excluding the GTV; R is the set of voxels in40
a 1 cm margin of normal tissue surrounding the PTV; O denotes the union of voxels in the41
duodenum, small bowel, large bowel, and stomach; and H is the set of all normal tissue voxels42
outside of the PTV that are not in L.43
44
The maximum BED bmaxi in the conformity objective depends linearly on the euclidean45
distance zi of a normal tissue voxel i from the PTV contour:46
bmaxi = 175  zi (175  40) (11)47
Hence, a fallo↵ of the BED from 175 Gy at the edge of the PTV to 40 Gy at 1 cm distance48
is aimed for, corresponding to a physical dose fall-o↵ from 50 Gy to 20 Gy for a uniformly49
2
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fractionated 5-fraction treatment.50
51
To find a local minimum of the optimization problem, we use our own implementation of52
the L-BFGS quasi-Newton method [3], together with an augmented Lagrangian method for53
handling constraints [1]. Calculation of the dose-deposition matrix elements Dij is performed54
with the open-source radiotherapy planning research platform CERR [2]. Fluence maps were55
initialized with small random intensities.56
B.2 Optimization of spatiotemporal plan 257
We denote the objective values for the GTV, PTV, chest wall, conformity, and healthy tissue58
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H . To obtain the spatiotemporal59






bi (mean liver BED) (12)61
62






















































Dijxtj 8i, t (20)70
xtj   0 8j, t (21)71
To obtain the spatiotemporal plan 2, the same optimization algorithm was used. The flu-72
ence maps were initialized using the spatiotemporal plan 1 with small random perturbations.73
Spatiotemporal plans 1 and 2 therefore resulted in qualitatively similar solutions.74
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C Results75
C.1 Spatiotemporal treatment plans76
Figure 5 shows the fractional doses delivered in the spatiotemporal treatment plans 2 for all77
patients. The treatment plans for patients 1, 2, 3 and 5 have in common that each fraction78
delivers high single fraction doses to complementary parts of the tumor. This compartmental-79
ization of the target volume is not manually determined. Instead, these dose distributions are80
found automatically through the optimization algorithm. The results for large tumors, such81
as for patient 5, show that the best treatment plans to achieve partial hypofractionation in82
the tumor along with more uniform fractionation in the normal liver are not obvious. Such83
plans would be di cult to design manually. Patient 4 di↵ers from the remaining patients as84
the tumor is surrounded by OARs with maximum BED constraint. Therefore, only a small85
degree of hypofractionation is achieved in the tumor as described in the main manuscript.86
The spatiotemporal plans 1 show the same qualitative features and similar dose distributions87
as the spatiotemporal plans 2.88
C.2 Quantifying the benefit of spatiotemporal fractionation89
In this paper, we report two spatiotemporal treatment plans to quantify the benefit over the90
uniformly fractionated reference plan. Spatiotemporal plan 1 is obtained by minimizing the91
same objective function as for the reference plan. Thereby, the benefit of spatiotemporal92
fractionation is distributed over multiple objectives. The spatiotemporal plan 1 reduces mean93
liver BED but also improves on target coverage and conformity. This has the disadvantage94
that the improvement is di cult to quantify. In spatiotemporal plan 2, the mean liver BED95
is minimized as the only objective, subject to the constraints that the plan is no worse than96
the reference plan in any other objective. Thereby all benefit of spatiotemporal fractionation97
is shifted into reduction of mean liver BED. This has the advantage that the improvement98
of the reference plan can quantified by a single number. However, it can lead to misleading99
observations in certain situations as seen for patients 4 and 5.100
101
For patient 4, a large discrepancy between spatiotemporal plan 1 and 2 regarding their liver102
BED reduction is observed (Table 2). For spatiotemporal plan 1, a small mean liver BED103
of 2% is observed. This is expected because the dose distributions delivered in each of the 5104
fractions is similar. The mean physical dose in the GTV is only 1% lower than in the refer-105
ence plan. This is due to the maximum BED constraint for OARs surrounding the tumor,106
which are best protected through uniform fractionation. For spatiotemporal plan 2, a large107
improvement is observed, which is not explained by the e↵ects of spatiotemporal fractionation108
alone. It is rather due to the location of spatiotemporal plan 1 on the pareto surface that109
characterizes the tradeo↵ between the 6 objectives. For this patient, a small relaxation of110
the first 5 objectives happens to allow for a large improvement in mean liver BED, the 6th111
objective. Hence, the large benefit observed for spatiotemporal plan 2 is technically correct112
but misleading.113
114
A similar e↵ect is observed for patient 5. The large benefit of 29% in spatiotemporal plan 2 is115
4
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not explained by the e↵ects of spatiotemporal fractionation alone. For this patient the tumor116
involves most of the right lobe. The degree to which the left lobe can be spared depends117
on the conformity of the plan and the dose delivered to the remaining healthy tissue outside118
of the liver. By sacrificing conformity, the dose delivered to the left lobe of the liver can be119
reduced substantially. Spatiotemporal plan 1 yields improvements to all 6 objectives relative120
to the reference plan. Compared to spatiotemporal plan 1, the first 5 objectives are relaxed in121
spatiotemporal plan 2, which allows for an overproportionate improvement in the mean liver122
BED.123
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Figure 5: Dose distributions delivered in 5 fractions for spatiotemporal plan 2. 6
